Majon Muller1, Sigurdur Sigurdsson1, Olafur Kjartansson1, Thor Aspelund1, Oscar L Lopez1, Palmi V Jonnson1, Tamara B Harris1, Mark van Buchem1, Vilmundur Gudnason1, Lenore J Launer2. 1. From the Laboratory of Epidemiology and Population Sciences (M.M., T.B.H., L.J.L.), Intramural Research Program, National Institute on Aging, Bethesda, MD; the Departments of Gerontology and Geriatrics (M.M.) and Radiology (M.v.B.), Leiden University Medical Center; Icelandic Heart Association (S.S., O.K., T.A., V.G.), Kopovagur; the Departments of Neurology & Radiology (O.K.) and Geriatrics (P.V.J.), Landspitali National University Hospital, Reykjavik, Iceland; the Department of Neurology (O.L.L.), University of Pittsburgh, PA; and the Faculty of Medicine (P.V.J.), University of Iceland, Reykjavik. 2. From the Laboratory of Epidemiology and Population Sciences (M.M., T.B.H., L.J.L.), Intramural Research Program, National Institute on Aging, Bethesda, MD; the Departments of Gerontology and Geriatrics (M.M.) and Radiology (M.v.B.), Leiden University Medical Center; Icelandic Heart Association (S.S., O.K., T.A., V.G.), Kopovagur; the Departments of Neurology & Radiology (O.K.) and Geriatrics (P.V.J.), Landspitali National University Hospital, Reykjavik, Iceland; the Department of Neurology (O.L.L.), University of Pittsburgh, PA; and the Faculty of Medicine (P.V.J.), University of Iceland, Reykjavik. LaunerL@nia.nih.gov.
Abstract
OBJECTIVE: We hypothesized that in participants with a history of hypertension, lower late-life blood pressure (BP) will be associated with more brain pathology. METHODS: Participants are 4,057 older men and women without dementia with midlife (mean age 50 ± 6 years) and late-life (mean age 76 ± 5 years) vascular screening, cognitive function, and brain structures on MRI ascertained as part of the Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study. RESULTS: The association of late-life BP to brain measures depended on midlife hypertension history. Higher late-life systolic and diastolic BP (DBP) was associated with an increased risk of white matter lesions and cerebral microbleeds, and this was most pronounced in participants without a history of midlife hypertension. In contrast, in participants with a history of midlife hypertension, lower late-life DBP was associated with smaller total brain and gray matter volumes. This finding was reflected back in cognitive performance; in participants with midlife hypertension, lower DBP was associated with lower memory scores. CONCLUSION: In this large population-based cohort, late-life BP differentially affects brain pathology and cognitive performance, depending on the history of midlife hypertension. Our study suggests history of hypertension is critical to understand how late-life BP affects brain structure and function.
OBJECTIVE: We hypothesized that in participants with a history of hypertension, lower late-life blood pressure (BP) will be associated with more brain pathology. METHODS:Participants are 4,057 older men and women without dementia with midlife (mean age 50 ± 6 years) and late-life (mean age 76 ± 5 years) vascular screening, cognitive function, and brain structures on MRI ascertained as part of the Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study. RESULTS: The association of late-life BP to brain measures depended on midlife hypertension history. Higher late-life systolic and diastolic BP (DBP) was associated with an increased risk of white matter lesions and cerebral microbleeds, and this was most pronounced in participants without a history of midlife hypertension. In contrast, in participants with a history of midlife hypertension, lower late-life DBP was associated with smaller total brain and gray matter volumes. This finding was reflected back in cognitive performance; in participants with midlife hypertension, lower DBP was associated with lower memory scores. CONCLUSION: In this large population-based cohort, late-life BP differentially affects brain pathology and cognitive performance, depending on the history of midlife hypertension. Our study suggests history of hypertension is critical to understand how late-life BP affects brain structure and function.
Authors: F E de Leeuw; J C de Groot; M Oudkerk; J C Witteman; A Hofman; J van Gijn; M M Breteler Journal: Ann Neurol Date: 1999-12 Impact factor: 10.422
Authors: Tom den Heijer; Ingmar Skoog; Matthijs Oudkerk; Frank-Erik de Leeuw; Jan Cees de Groot; Albert Hofman; Monique M B Breteler Journal: Neurobiol Aging Date: 2003 Mar-Apr Impact factor: 4.673
Authors: Behnam Sabayan; Anna M Oleksik; Andrea B Maier; Mark A van Buchem; Rosalinde K E Poortvliet; Wouter de Ruijter; Jacobijn Gussekloo; Anton J M de Craen; Rudi G J Westendorp Journal: J Am Geriatr Soc Date: 2012-11-05 Impact factor: 5.562
Authors: Nigel S Beckett; Ruth Peters; Astrid E Fletcher; Jan A Staessen; Lisheng Liu; Dan Dumitrascu; Vassil Stoyanovsky; Riitta L Antikainen; Yuri Nikitin; Craig Anderson; Alli Belhani; Françoise Forette; Chakravarthi Rajkumar; Lutgarde Thijs; Winston Banya; Christopher J Bulpitt Journal: N Engl J Med Date: 2008-03-31 Impact factor: 91.245
Authors: Hadassa M Jochemsen; Majon Muller; Frank L Visseren; Philip Scheltens; Koen L Vincken; Willem P Mali; Yolanda van der Graaf; Mirjam I Geerlings Journal: JAMA Neurol Date: 2013-08 Impact factor: 18.302
Authors: Minjie Wu; Omalara Fatukasi; Shaolin Yang; Jeffery Alger; Peter B Barker; Hoby Hetherington; Tae Kim; Andrew Levine; Eileen Martin; Cynthia A Munro; Todd Parrish; Ann Ragin; Ned Sacktor; Eric Seaberg; James T Becker Journal: AIDS Date: 2018-08-24 Impact factor: 4.177
Authors: Costantino Iadecola; Kristine Yaffe; José Biller; Lisa C Bratzke; Frank M Faraci; Philip B Gorelick; Martha Gulati; Hooman Kamel; David S Knopman; Lenore J Launer; Jane S Saczynski; Sudha Seshadri; Adina Zeki Al Hazzouri Journal: Hypertension Date: 2016-10-10 Impact factor: 10.190
Authors: Keenan A Walker; A Richey Sharrett; Aozhou Wu; Andrea L C Schneider; Marilyn Albert; Pamela L Lutsey; Karen Bandeen-Roche; Josef Coresh; Alden L Gross; B Gwen Windham; David S Knopman; Melinda C Power; Andreea M Rawlings; Thomas H Mosley; Rebecca F Gottesman Journal: JAMA Date: 2019-08-13 Impact factor: 56.272
Authors: Melinda C Power; Andrea L C Schneider; Lisa Wruck; Michael Griswold; Laura H Coker; Alvaro Alonso; Clifford R Jack; David Knopman; Thomas H Mosley; Rebecca F Gottesman Journal: Alzheimers Dement Date: 2016-04-29 Impact factor: 21.566
Authors: Emer R McGrath; Alexa S Beiser; Charles DeCarli; Kendra L Plourde; Ramachandran S Vasan; Steven M Greenberg; Sudha Seshadri Journal: Neurology Date: 2017-11-08 Impact factor: 9.910